Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin | Zendy

R. Milošević | Zendy; Novak Milović | Zendy; Predrag Aleksić | Zendy; Miodrag Lazić | Zendy; Snežana Cerović | Zendy; Vladimir Bančević | Zendy; Branko Kosevic | Zendy; Predrag Marić | Zendy; Aleksandar Spasić | Zendy; Dejan Simić | Zendy; Božidar Kovačević | Zendy

Open Access

Difference in recurrence frequencies of non-muscle-invasive-bladder tumors depending on optimal usage of intravesical immunotherapy of bacillus Calmette-Guérin

Author(s) -

R. Milošević,

Novak Milović,

Predrag Aleksić,

Miodrag Lazić,

Snežana Cerović,

Vladimir Bančević,

Branko Kosevic,

Predrag Marić,

Aleksandar Spasić,

Dejan Simić,

Božidar Kovačević

Publication year - 2014

Publication title -

vojnosanitetski pregled

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.123

H-Index - 19

eISSN - 2406-0720

pISSN - 0042-8450

DOI - 10.2298/vsp131030072m

Subject(s) - medicine , bladder cancer , bladder tumor , significant difference , group b , randomized controlled trial , urology , surgery , group a , cancer , gastroenterology

The therapy with intravesical instillation of bacillus Calmette-Guérin (BCG) after transurethral resection (ITJR) of the tumor is the gold standard of treatment of non-muscle invasive bladder cancer (NMIBC). The aim of this study was to compare the frequencies of reccurence between a group of patients submitted to TUR + BCG therapy (group I) and a group of patients submitted only to TUR (group II).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research